Developing a device to monitor HIV viral load and medication adherence
NIMH SBIR PHASE I TOPIC 001- POINT-OF-CARE HIV VIRAL LOAD AND DRUG ADHERENCE ASSAYS
['FUNDING_OTHER'] · GUILD ASSOCIATES, INC. · NIH-11222478
This study is testing a new device that helps people with HIV check their viral load and medication levels at home, making it easier for them to stay on top of their health and share important information with their doctors.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GUILD ASSOCIATES, INC. (nih funded) |
| Locations | 1 site (DUBLIN, UNITED STATES) |
| Trial ID | NIH-11222478 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a device that allows individuals living with HIV to monitor their viral load and medication adherence at home or in a point-of-care setting. The device will provide users with qualitative results regarding their HIV status and the concentration of therapeutic drugs in their system. This information can be shared with healthcare providers to ensure optimal treatment and management of HIV. The project aims to enhance patient engagement and self-management in their healthcare.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are seeking to improve their health management and treatment adherence.
Not a fit: Patients who are not living with HIV or those who are not on antiretroviral therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could empower patients with HIV to better manage their condition through real-time monitoring of their viral load and medication adherence.
How similar studies have performed: Other research has shown promise in developing point-of-care devices for monitoring HIV, indicating a potential for success in this approach.
Where this research is happening
DUBLIN, UNITED STATES
- GUILD ASSOCIATES, INC. — DUBLIN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SMIECHOWSKI, MATTHEW FRANCIS — GUILD ASSOCIATES, INC.
- Study coordinator: SMIECHOWSKI, MATTHEW FRANCIS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus, HIV Infections, HTLV-III Infections